nlisting
Richard Burton and Elizabeth Taylor and a high-tech eye-tracking device
developed for the military, researchers at Yale ran experiments that came closer
than anything yet to offering a look at the world as seen through the eyes of
people with autism.
In one experiment, described in the current issue of The American Journal of
Psychiatry, the researchers compared the eye movements of a highly intelligent
autistic adult and a control subject of the same age, sex and I.Q. as they
watched the relentless emotional conflicts of "Who's Afraid of Virginia Woolf?"
What the experiment showed was that the two subjects were seeing the movie in
starkly different ways. When Mr. Burton and Ms. Taylor, playing an alcoholic
professor and his shrewish wife, confronted each other face to face, the gaze of
the nonautistic adult swung intently between their eyes, while the autistic
subjects looked back and forth, as well but focused on the actors' mouths.
When Ms. Taylor flirted with George Segal, playing a young professor, as her
husband lurked in the background, the gaze of the nonautistic adult described a
triangle as he followed the expressions of all three. The autistic man never
looked at Mr. Burton or anyone's eyes.
Dr. Ami Klin, a psychologist at the Yale Child Study Center who was the lead
author of the study, said his team chose the movie because it presented complex
social situations that involved just four characters and had few distracting
inanimate objects.
To track eye movements, the researchers used a device made by Iscan of
Burlington, Mass., said Warren Jones, a research associate who worked on the
technical end of the experiment. He said eye-tracking technology had originally
been developed largely with military funds to create a look-and-load system for
fighter pilots.
The system in the Yale experiment looked like a baseball cap with two cameras
attached. One camera, at cheek level, faces forward and records the field of
view. An infrared camera on the bill points down to a piece of glass that hangs
in front of the eyes and acts as a mirror, letting the cameras capture eye
position changes without blocking the subject's view.
Dr. Klin said the device offered a tool to deal with one of the most
frustrating research problems in studying autism, a little-understood brain
disorder whose diagnosis has become increasingly common. Although autism affects
a broad range of skills, the Yale researchers consider its central feature to be
"a profound social disability," in Dr. Klin's words.
But when social tasks are broken down into discrete components suitable for
research, autistic children can perform far better than in the hurly-burly of
real social challenges like recess, he said.
The eye-tracking device allows researchers "to see what they see" while
engaged in a more natural task, said Dr. Klin. "But we're less interested in
what they understood than in how they searched for meaning," he said.
What the researchers saw in the "Virginia Woolf" study and in a larger
follow-up trial that autistic people tend to look at mouths or extraneous
objects when nonautistic people look at eyes fits in with other classic signs
of autism like limited eye contact and difficulty in remembering faces.
Dr. Klin called it especially intriguing because normally developing infants
learn, often as early as 3 months, to look at people's eyes instead of their
mouths when searching for information about feelings and intentions.
Although autism is thought to affect brain development even before birth, in
most children it is not diagnosed until age 3 or 4 or even later, when symptoms
like language deficiencies or repetitive behaviors become evident. The Yale
group has begun experiments to see whether eye-tracking tests could lead to
earlier diagnoses because the best results come from intensive treatments that
begin as soon as possible.
Dr. Klin said eye-tracking fitted into a developing theory about the delay in
symptoms. The problem is not just abnormal brain structure, but a stunting of
brain development because of the limited social input that comes from a focus on
objects rather than people.
"We are," he said, "the sum of all our experiences."
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
Sandy's Scandals Column
Past and current Scandals
- columns by Sandy Gottstein (aka Mintz)*
* ►February 8, 2010 - Inovio
Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related
Immune Response in Clinical Trial - Inovio via BusinessWire
via Technology Marketing Corporation - "VGX-3100 is a DNA vaccine
targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16
and 18 and is delivered via in vivo electroporation. Similar to
previously reported data from the initial lowest dose cohort of this
phase I trial, the vaccine was found to be generally safe and well
tolerated. While previously reported data showed significant cellular
and humoral immune responses, data from this second, intermediate dose
group highlighted a significantly increased and dose-related immune
response specific to the antigens targeted by the vaccine."..."While
recent HPV preventive vaccines have been successful in protecting
against infections that may lead to cervical cancer, Inovio's
therapeutic vaccine targets the millions of women already infected with
HPV and is intended to treat pre-cancerous cells and cervical cancer
caused by this virus. Current vaccines do not serve this group of
women," Dr. Kim added."
* ►February 6, 2010 - Autism
Findings Retracted
- The New American - "Actress Holly Robinson Peete remembers, 'When my
son was two-and-a-half, he was just recovering from an ear infection
and had been on antibiotics, therefore his immune system was
suppressed. He had already missed several appointments for his
vaccination so his pediatrician wanted to catch him up on all of them
in the same day. Althrough I asked if he’d consider waiting or breaking
up the cocktail, which contains three viruses, he laughed me out of the
office and belittled me. I firmly believe that it took my son to a
place of no return and his body could not handle it. He had a violent
reaction with convulsions and then he stopped talking and slipped into
a silence. He no longer said, 'Hi, Mommy,' he no longer responded to
his name and he no longer made eye contact.”